ME
Global Health Limited
MEDANTA.BO · BSE
₹1,472.85 +3.81% (+₹54.00)
1M +0.95%
Market Cap ₹382.1B
P/E Ratio 68.70x
Div. Yield 0.04%
ROE 15.07%
Bulios Fair Price
₹1,201
18.4% downside
Current Price
₹1,473
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MEDANTA.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 9.65x
P/S 8.16x
P/E 68.70x
Growth
100 /100
Growing Book val. growth 27.97%
FCF growth 42.84%
EPS growth 32.35%
Profitability
54 /100
Moderate FCF margin 1.80%
Op. margin 15.64%
Gross margin 61.75%
Quality
67 /100
Excellent Asset turnover 0.79x
ROA 9.42%
ROIC 10.52%
Debt
96 /100
Low Net debt/EBITDA 0.06x
Int. coverage 8.83x
Debt/Equity 0.30x
Stability
64 /100
Moderate Profitable years 6
EPS volatility 31.50%
Beta 0.16x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MEDANTA.BO
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Pankaj Sahni
Employees
12,600
Headquarters
Gurugram
Upcoming events
06 NOV
Earnings
Upcoming earnings report